Alkali Therapy Attenuates the Progression of Kidney Injury Via Na/H Exchanger Inhibition in 5/6 Nephrectomized Rats

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2014 May 23

PMID 24851027

Citations 3

Authors

Sejoong Kim

Jeonghwan Lee

Nam Ju Heo

Jae Wook Lee

Jin Suk Han

Affiliations

Soon will be listed here.

Abstract

Metabolic acidosis is a cause of renal disease progression, and alkali therapy ameliorates its progression. However, there are few reports on the role of renal acid-base transporters during alkali therapy. We evaluated the effect of sodium bicarbonate therapy and the role of acid-base transporters on renal disease progression in rats with a remnant kidney. Sprague-Dawley rats consumed dietary sodium bicarbonate (NaHCO3) or sodium chloride (NaCl) with 20% casein after a 5/6 nephrectomy. After being provided with a casein diet, the NaHCO3-treated group had higher levels of serum bicarbonate than the control group. At week 4, the glomerular filtration rate in the NaHCO3 group was higher than that in the NaCl group, and the difference became prominent at week 10. The glomerulosclerosis and tubulointerstitial damage indices in the NaHCO3 group were less severe compared with controls at week 4 and 10. The expression of the Na/H exchanger (NHE) was decreased, and apical reactivity was decreased in the NaHCO3 group, compared with the NaCl group. Endothelin-1 levels in the kidney were also decreased in the NaHCO3 group. Dietary sodium bicarbonate has the effects of ameliorating renal disease progression, which may be related to the altered expression of NHE in the remaining kidney.

Citing Articles

Cognitive Sequelae and Hippocampal Dysfunction in Chronic Kidney Disease following 5/6 Nephrectomy.

Yu Y, Kim S, Im H, Oh S, Cho N, Park S Brain Sci. 2022; 12(7).

PMID: 35884712 PMC: 9321175. DOI: 10.3390/brainsci12070905.

Alkali supplementation as a therapeutic in chronic kidney disease: what mediates protection?.

Mannon E, OConnor P Am J Physiol Renal Physiol. 2020; 319(6):F1090-F1104.

PMID: 33166183 PMC: 7792697. DOI: 10.1152/ajprenal.00343.2020.

Effects of sodium citrate on salt sensitivity and kidney injury in chronic renal failure.

Kim S, Yang J, Jung E, Lee J, Heo N, Lee J J Korean Med Sci. 2014; 29(12):1658-64.

PMID: 25469066 PMC: 4248587. DOI: 10.3346/jkms.2014.29.12.1658.

References

Kim G, Martin S, Fernandez-Llama P, Masilamani S, Packer R, Knepper M . Long-term regulation of renal Na-dependent cotransporters and ENaC: response to altered acid-base intake. Am J Physiol Renal Physiol. 2000; 279(3):F459-67. DOI: 10.1152/ajprenal.2000.279.3.F459. View

Laghmani K, Borensztein P, Ambuhl P, Froissart M, Bichara M, Moe O . Chronic metabolic acidosis enhances NHE-3 protein abundance and transport activity in the rat thick ascending limb by increasing NHE-3 mRNA. J Clin Invest. 1997; 99(1):24-30. PMC: 507763. DOI: 10.1172/JCI119128. View

Nath K, Hostetter M, Hostetter T . Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest. 1985; 76(2):667-75. PMC: 423874. DOI: 10.1172/JCI112020. View

Laghmani K, Preisig P, Alpern R . The role of endothelin in proximal tubule proton secretion and the adaptation to a chronic metabolic acidosis. J Nephrol. 2002; 15 Suppl 5:S75-87. View

Cingolani H, Rebolledo O, Portiansky E, Perez N, Camilion de Hurtado M . Regression of hypertensive myocardial fibrosis by Na(+)/H(+) exchange inhibition. Hypertension. 2003; 41(2):373-7. DOI: 10.1161/01.hyp.0000051502.93374.1c. View

Bhalla V, Hallows K . Mechanisms of ENaC regulation and clinical implications. J Am Soc Nephrol. 2008; 19(10):1845-54. DOI: 10.1681/ASN.2008020225. View

Gadola L, Noboa O, Marquez M, Rodriguez M, Nin N, Boggia J . Calcium citrate ameliorates the progression of chronic renal injury. Kidney Int. 2004; 65(4):1224-30. DOI: 10.1111/j.1523-1755.2004.00496.x. View

Mahajan A, Simoni J, Sheather S, Broglio K, Rajab M, Wesson D . Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int. 2010; 78(3):303-9. DOI: 10.1038/ki.2010.129. View

Yamashita J, Ohkita M, Takaoka M, Kaneshiro Y, Matsuo T, Kaneko K . Role of Na+/H+ exchanger in the pathogenesis of ischemic acute renal failure in mice. J Cardiovasc Pharmacol. 2007; 49(3):154-60. DOI: 10.1097/FJC.0b013e318030c2c9. View

10.

de Brito-Ashurst I, Varagunam M, Raftery M, Yaqoob M . Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009; 20(9):2075-84. PMC: 2736774. DOI: 10.1681/ASN.2008111205. View

11.

Frassetto L, Hsu C . Metabolic acidosis and progression of chronic kidney disease. J Am Soc Nephrol. 2009; 20(9):1869-70. DOI: 10.1681/ASN.2009070710. View

12.

Licht C, Laghmani K, Yanagisawa M, Preisig P, Alpern R . An autocrine role for endothelin-1 in the regulation of proximal tubule NHE3. Kidney Int. 2004; 65(4):1320-6. DOI: 10.1111/j.1523-1755.2004.00506.x. View

13.

Kim Y, Kwon T, Frische S, Kim J, Tisher C, Madsen K . Immunocytochemical localization of pendrin in intercalated cell subtypes in rat and mouse kidney. Am J Physiol Renal Physiol. 2002; 283(4):F744-54. DOI: 10.1152/ajprenal.00037.2002. View

14.

Kim S, Heo N, Jung J, Son M, Jang H, Lee J . Changes in the sodium and potassium transporters in the course of chronic renal failure. Nephron Physiol. 2010; 115(4):p31-41. DOI: 10.1159/000314542. View

15.

Wesson D, Nathan T, Rose T, Simoni J, Tran R . Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production. Kidney Int. 2006; 71(3):210-7. DOI: 10.1038/sj.ki.5002036. View

16.

Pech V, Pham T, Hong S, Weinstein A, Spencer K, Duke B . Pendrin modulates ENaC function by changing luminal HCO3-. J Am Soc Nephrol. 2010; 21(11):1928-41. PMC: 3014007. DOI: 10.1681/ASN.2009121257. View

17.

Na K, Kim G, Joo K, Lee J, Jang H, Oh Y . Chronic furosemide or hydrochlorothiazide administration increases H+-ATPase B1 subunit abundance in rat kidney. Am J Physiol Renal Physiol. 2007; 292(6):F1701-9. DOI: 10.1152/ajprenal.00270.2006. View

18.

Linz W, Busch A . NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling. Naunyn Schmiedebergs Arch Pharmacol. 2003; 368(4):239-46. DOI: 10.1007/s00210-003-0808-2. View

19.

Bobulescu I, Moe O . Luminal Na(+)/H (+) exchange in the proximal tubule. Pflugers Arch. 2008; 458(1):5-21. PMC: 2878283. DOI: 10.1007/s00424-008-0595-1. View

20.

Mount D, Sibella V, Vernimmen C, Hebert S, Bichara M . Stimulation by in vivo and in vitro metabolic acidosis of expression of rBSC-1, the Na+-K+(NH4+)-2Cl- cotransporter of the rat medullary thick ascending limb. J Biol Chem. 1998; 273(50):33681-91. DOI: 10.1074/jbc.273.50.33681. View